Your browser doesn't support javascript.
loading
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis.
Sim, B Kim Lee; Li, Minglin; Osorio, Manuel; Wu, Yun; Wai, Tint T; Peterson, Johnny W; James, Eric R; Chakravarty, Sumana; Gao, Lixin; Xu, Rui; Kc, Natasha; Stafford, Richard E; Lawrence, William S; Yeager, Linsey A; Peel, Jennifer E; Sivasubramani, Satheesh K; Chopra, Ashok K; Filippova, Svetlana; Hoffman, Stephen L.
Afiliación
  • Sim BKL; Protein Potential LLC, Rockville, MD 20850 USA.
  • Li M; Protein Potential LLC, Rockville, MD 20850 USA.
  • Osorio M; U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Silver Spring, MD 20993 USA.
  • Wu Y; Protein Potential LLC, Rockville, MD 20850 USA.
  • Wai TT; Protein Potential LLC, Rockville, MD 20850 USA.
  • Peterson JW; Department of Microbiology and Immunology, Galveston National Laboratory, Center for Biodefense and Emerging Infectious Diseases, and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555 USA.
  • James ER; Sanaria Inc, Rockville, MD 20850 USA.
  • Chakravarty S; Sanaria Inc, Rockville, MD 20850 USA.
  • Gao L; Protein Potential LLC, Rockville, MD 20850 USA.
  • Xu R; Protein Potential LLC, Rockville, MD 20850 USA.
  • Kc N; Protein Potential LLC, Rockville, MD 20850 USA.
  • Stafford RE; Protein Potential LLC, Rockville, MD 20850 USA.
  • Lawrence WS; Department of Microbiology and Immunology, Galveston National Laboratory, Center for Biodefense and Emerging Infectious Diseases, and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555 USA.
  • Yeager LA; Department of Microbiology and Immunology, Galveston National Laboratory, Center for Biodefense and Emerging Infectious Diseases, and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555 USA.
  • Peel JE; Department of Microbiology and Immunology, Galveston National Laboratory, Center for Biodefense and Emerging Infectious Diseases, and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555 USA.
  • Sivasubramani SK; Department of Microbiology and Immunology, Galveston National Laboratory, Center for Biodefense and Emerging Infectious Diseases, and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555 USA.
  • Chopra AK; Department of Microbiology and Immunology, Galveston National Laboratory, Center for Biodefense and Emerging Infectious Diseases, and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555 USA.
  • Filippova S; U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Silver Spring, MD 20993 USA.
  • Hoffman SL; Protein Potential LLC, Rockville, MD 20850 USA.
NPJ Vaccines ; 2: 17, 2017.
Article en En | MEDLINE | ID: mdl-29263873
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2017 Tipo del documento: Article